MiniMed Group, Inc.
For the period ended Jul 31, 2026. Filed Sep 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2026 · Filed Sep 8, 2026
MMED$16.71-8.0%Stored close · as of Nov 6, 2026
Contents
Consolidated Statements of Operations for the Three Months Ended July , 202 and
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended | ||
|---|---|---|
| (in millions, except per share data) | July 31, 2026 | July 25, 2025 |
| Net sales | $843 | $723 |
| Cost of products sold | 378 | 314 |
| Gross profit | 465 | 409 |
| Operating expenses: | ||
| Research and development expense | 115 | 125 |
| Selling, general, and administrative expense | 312 | 283 |
| Certain litigation charges, net | (2) | 17 |
| Other operating expense (income), net | 36 | (2) |
| Operating income (expense) | 5 | (13) |
| Other non-operating expense (income), net | — | — |
| Income (loss) before income taxes | 4 | (13) |
| Income tax provision | 4 | 3 |
| Net income (loss) | — | (16) |
| Net income attributable to noncontrolling interests | — | (3) |
| Net income (loss) attributable to the Company | $— | $(19) |
| Earnings (loss) per share: | ||
| Basic and diluted | $0.00 | $(0.08) |
| Weighted-average shares outstanding | ||
| Basic and diluted | 281.0 | 252.8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.